Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer

ABSTRACT: In this experiment, we evaluted whole transcriptomic changes in ex vivo cultured ducts expressing mutant Kras compared to control ducts. The cells were cultured for 7 days before RNA was isolated for RNA-seq.

ORGANISM(S): Mus musculus

PROVIDER: GSE189129 | GEO | 2023/07/24

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer

Project description:Kras and Trp53 mutations promote transformation in pancreatic acinar and ductal cells. We wanted to evaluate whole transcriptomic profiles of acinar and ductal derived tumors. In addition, we studied whole transcriptomic changes in ex vivo cultured ducts expressing mutant Kras compared to control ducts.

2023-07-24 | GSE189128 | GEO

CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer

Project description:This SuperSeries is composed of the SubSeries listed below.

2023-07-24 | GSE189130 | GEO

Inhibition of miR-21 regulates mutant KRAS effector pathways and intercepts pancreatic ductal adenocarcinoma development

Project description:We identified miR-21 and miR-224 as cell-specific and compartment-specific regulators in PanINs and PDA. miR-21 is overexpressed in tumor epithelial cells of premalignant ducts, while miR-224 is overexpressed in cancer-associated fibroblasts in PDA stroma. Inhibition of miR-21 reverted pro-tumorigenic functionalities to baseline levels. Overexpression of miR-224 induced activated phenotypes in normal fibroblasts. miR-21 inhibition downregulated MAPK, mTOR and actin cytoskeleton pathways downstream of KRAS activation in tumor cells. In vivo miR-21 inhibition improved survival in established PDA, while early systemic miR-21 inhibition intercepted premalignant progression.

2020-07-29 | GSE143326 | GEO

Inhibition of miR-21 regulates mutant KRAS effector pathways and intercepts pancreatic ductal adenocarcinoma development [miRNA]

2020-07-29 | GSE143648 | GEO

Mutant p53R270H drives altered metabolism and increased invasion in pancreatic ductal adenocarcinoma

Project description:Pancreatic cancer is characterized by nearly universal activating mutations in KRAS. Among other somatic mutations, TP53 is mutated in more than 75% of human pancreatic tumors. Genetically engineered mice have proven instrumental in studies of the contribution of individual genes to carcinogenesis. Oncogenic Kras mutations occur early during pancreatic carcinogenesis and are considered an initiating event. In contrast, mutations in p53 occur later during tumor progression. In our model, we recapitulated the order of mutations of the human disease, with p53 mutation following expression of oncogenic Kras. Further, using an inducible and reversible expression allele for mutant p53, we inactivated its expression at different stages of carcinogenesis. Notably, the function of mutant p53 changes at different stages of carcinogenesis. Our work establishes a requirement for mutant p53 for the formation and maintenance of pancreatic cancer precursor lesions. In tumors, mutant p53 becomes dispensable for growth. However, it maintains the altered metabolism that characterizes pancreatic cancer and mediates its malignant potential. Further, mutant p53 promotes epithelial-mesenchymal transition (EMT) and cancer cell invasion. This work generates new mouse models that mimic human pancreatic cancer and expands our understanding of the role of p53 mutation, common in the majority of human malignancies.

2018-09-05 | GSE106853 | GEO

Immunosuppression via adenosine receptor activation by adenosine monophosphate released from apoptotic cells.

Project description: Not available

| S-EPMC3963506 | biostudies-literature

CD73+ extracellular vesicles inhibit angiogenesis through adenosine A2B receptor signalling.

Project description: Not available

| S-EPMC7241475 | biostudies-literature

CD73 Controls Extracellular Adenosine Generation in the Trigeminal Nociceptive Nerves.

Project description: Not available

| S-EPMC5444617 | biostudies-literature

Gene expression profile of transformed pancreatic ductal cells

Project description:We observed that upon the activation of the oncogene KRasG12D and the deletion of the tumour suppressor Fbw7 in pancreatic ducts (KFCkY model), not all ducts respond in the same way. Some ductal cells remain morphologically normal while others exhibit signs of transformation (cellular and nuclear enlargement) with the concomitant upregulation of CD44. Here we wanted to understand the differences between the normal-looking and transformed cells at the transcriptional level.

2019-08-28 | GSE121864 | GEO

CD73-positive extracellular vesicles promote glioblastoma immunosuppression by inhibiting T-cell clonal expansion.

Project description: Not available

| S-EPMC8578373 | biostudies-literature